Cleveland Clinic Cancer Advances

Emre Gorgun, MD, colorectal surgeon and co-director of Cleveland Clinic's Colorectal Cancer Program, joins the Cancer Advances podcast to discuss our non-operative organ sparing approach for rectal cancer. Listen as Dr. Gorgun explains how this new care path allows about a third of stage II and III locally advanced rectal cancer patients avoid surgery.

Carrie Emch, Program Coordinator for the Cleveland Clinic 4th Angel Mentoring Program, joins the Cancer Advances podcast to discuss the program and how patients and caregivers benefit. Listen as she highlights the programs interactive approach to cancer support, the peer-to-peer matching process, and how you can get involved.

Rabi Hanna, MD, Chair of Pediatric Hematology, Oncology and Blood and Marrow Transplantation at Cleveland Clinic Children's joins the Cancer Advances podcast to discuss best practices for treating pediatric and young adult cancer patients with autism spectrum disorder (ASD). Listen as Dr. Hanna discusses how we treat the patient, not the disease. By making simple adjustments and individualizi...

Cleveland Clinic oncologist, Allison Winter, MD, joins the Cancer Advances podcast to discuss Cleveland Clinic's Central Nervous System (CNS) Lymphoma Transplant Program. Listen as Dr. Winter covers how the program started, our multidisciplinary approach to care and which patients with primary CNS lymphoma might benefit most.

Cleveland Clinic Cancer Center Hospice and Palliative Care Specialist, Cory Chevalier, MD, joins the Cancer Advances podcast to discuss palliative care. Listen as Dr. Chevalier discusses our unique model in how we integrate palliative care by using a multidisciplinary approach in both an inpatient and clinical setting.

Robert DeBernardo, MD, Section Head of Gynecologic Oncology at Cleveland Clinic Ob/Gyn & Women’s Health Institute joins the Cancer Advances podcast to discuss hyperthermic intra-peritoneal chemotherapy (HIPEC), specifically in gynecologic cancers. Listen as Dr. DeBernardo discusses the procedure and use of HIPEC along with the type of patient and cancers that are ideal for HIPEC treatment.

Samuel Chao, MD, radiation oncologist in the Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center of Cleveland Clinic Neurological Institute and Cleveland Clinic Cancer Center, joins the Cancer Advances podcast to talk about the work he recently presented at the American Society of Radiation Oncology (ASTRO) 2020 Annual Meeting. Listen as Dr. Chao discusses preliminary results from a recent C...

Cleveland Clinic Center Director for Musculoskeletal Oncology, Nathan Mesko, MD, joins the Cancer Advances podcast to discuss how Cleveland Clinic is managing sarcoma and cancers involving the bone and soft tissue. Listen as Dr. Mesko covers time to treat in sarcoma patients, the breadth of specialties involved in our multidisciplinary approach to care and how we are collaborating with other Insti...

Eric Klein, MD, Chairman of Cleveland Clinic’s Glickman Urological & Kidney Institute joins the Cancer Advances podcast to discuss the IsoPSA Test, now being offered at Cleveland Clinic. The IsoPSA test is a novel prostate-specific antigen assay for patients with a PSA > 4ng/ml who are facing a decision on prostate biopsy. Listen as Dr. Klein discusses how the IsoPSA test differs from conve...

Sudipto Mukherjee, MD, MPH, Director of Rare Cancers and Blood Diseases at Cleveland Clinic, joins the Cancer Advances podcast to discuss our approach to rare cancers. Patients with rare cancers and blood diseases often have difficulty finding clinicians with necessary expertise. Listen as Dr. Mukherjee discusses how Cleveland Clinic Cancer Center's Rare Cancers and Blood Diseases initiative...

Just like traits such as eye color or height, an increased risk to form certain types of cancers can also be genetic. Approximately 5% of all colorectal cancer cases are hereditary, and Dr. David Liska, Director of Cleveland Clinic's Sanford R. Weiss, MD Center for Hereditary Colorectal Neoplasia, joins Cancer Advances to discuss these cancers and how the multidisciplinary team at The Weiss C...

Alok Khorana, MD, Director of The Gastrointestinal Malignancies Program and Vice Chair for Career Academic Development at Cleveland Clinic, joins the Cancer Advances podcast to discuss some of his key takeaways from ASCO 2020, along with the important role clinical trials play in cancer advancements, especially GI cancers.

Newer therapies are not only allowing us to care for our cancer patients better, but oftentimes, it helps increase lifespans with fewer toxicities. Laurie Matt-Amaral, MD, MPH, who specializes in Hematology Oncology at Cleveland Clinic Akron General’s McDowell Cancer Center, joins the Cancer Advances podcast to discuss target therapies for lung cancer. Listen as Dr. Matt-Amaral shares her insights...

Cleveland Clinic Cancer Center regional medical oncologist, Kasra Karamlou, MD, joins the Cancer Advances podcast to discuss the management of myeloma and how regional facilities collaborate with main campus to bring the same high level care to their patients locally.

Brian Gastman, MD, Plastic Surgeon and Medical and Surgical Director of the Melanoma and High-risk Skin Cancer Program at Cleveland Clinic, joins Cancer Advances to discuss the latest in Merkel Cell Carcinoma. He touches on treatment options, research and results, along with what we can expect to see in the coming years.

Conor Delaney, MD, PhD, President and CEO of the Cleveland Clinic Florida region, joins the Cancer Advances podcast to discuss minimally invasive surgery (MIS). Listen as Dr. Delaney shares his insight on which patients and types of cancer benefit most from MIS, the importance of a multidisciplinary team and what referring physicians should look for when considering who should do their patient&apo...

Single-fraction SBRT is safe and effective in treating early stage, medically inoperable NSCLC, according to a ten-year retrospective study of 229 patients, the largest single-institution report to date. Gregory Videtic, MD, radiation oncologist at Cleveland Clinic Cancer Center, joins the Cancer Advances podcast to discuss the findings that were presented at the American Society for Radiation Onc...

Cleveland Clinic hematologist/oncologist, Bhumika Patel, MD, joins the Cancer Advances podcast to discuss Cleveland Clinic Cancer Center's new CHIP Clinic. The CHIP Clinic screens and monitors patients with clonal hematopoiesis of indeterminate potential (CHIP): somatic mutations in blood or bone marrow cells that increase the risk of blood cancers and heart disease. Listen as Dr. Patel share...

Jame Abraham, MD, Chair of the Department of Hematology and Medical Oncology at the Cleveland Clinic Cancer Center, joins the Cancer Advances podcast to discuss the latest in breast cancer clinical trials. Listen as Dr. Abraham shares his insight on how to get the word out to patients about clinical trials, the role COVID-19 has played in trial logistics, along with which trials he thinks are like...

John Suh, MD, Chair of the Department of Radiation Oncology at Cleveland Clinic Cancer Center, joins the Cancer Advances podcast to discuss leadership development. Dr. Suh shares his personal journey on becoming a leader. He highlights the important role coaching and mentorship, self-reflection and emotional intelligence has in continuous improvement.

Chirag Shah, MD, Director of Breast Radiation and Clinical Research in the Department of Radiation Oncology at Cleveland Clinic, joins the Cancer Advances podcast to discuss the latest in breast cancer radiation. Dr. Shah shares how radiation for the breast has evolved over the past decade, giving breast cancer patients multiple options for radiation treatment. Listen as Dr. Shah discusses how we...

Genetic testing and screening in gynecologic cancer patients has evolved over the last several years. Miriam AlHilli, MD joins the Cancer Advances podcast to discuss the latest in genetic testing, screening and prevention.

Colorectal cancer is typically the second or third leading cause of cancer-related death in the United States. Scott Steele, MD, Chair of Colorectal Surgery at Cleveland Clinic joins the podcast to discuss updated screening guidelines and recommended methods, as well as the alarming increase in early-onset colorectal cancer.

Upon completing cancer treatment, a patient’s journey is truly just beginning. Halle Moore, MD, Director of Breast Medical Oncology and Co-Director of the Comprehensive Breast Cancer Program discusses Cleveland Clinic’s breast cancer survivorship program. Listen as Dr. Moore shares her learnings from more than a decade of research to improve the quality of life for cancer survivors.

Cleveland Clinic Cancer Center oncologist Shilpa Gupta, MD discusses promising findings in the treatment of advanced bladder cancer in this week's Cancer Advances podcast. Dr. Gupta shares data from the phase II Bladder Cancer Signal Seeking Trial (BLASST-1), recently presented at the American Society of Clinical Oncology’s Genitourinary Cancers Symposium. She also provides an update on addit...